5% Topical Ibuprofen (IBU) for Ankle Sprain

Completed · Phase 3 · Has a placebo group

Conditions studied: Ankle Injuries

In brief

This study is being conducted to evaluate the effects of IBU 5% Topical Gel versus topical placebo for the relief of pain associated with a first or second degree ankle sprain. Both twice daily and three times daily regimens will be evaluated.

Key facts

Study ID
NCT01945034
Run by
Pfizer
People needed
304
Starts
2013-11-01
Expected to finish
2015-02-01
Last updated by the study team
2016-05-26

Who can join

Age: 12 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.